| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/15/1993 | CA2120622A1 Activation-dependent protein expressed on the surface of activated platelets and antibodies thereto |
| 04/15/1993 | CA2120601A1 Sperm surface protein |
| 04/15/1993 | CA2120500A1 Preventing allograft rejection with antibodies to adhesion molecules |
| 04/15/1993 | CA2120329A1 Detection of human p58 protein kinase and its dna for diagnosis of certain cancers |
| 04/15/1993 | CA2120328A1 Purified chitin deacetylase |
| 04/15/1993 | CA2120240A1 Inhibition of vascular narrowing using anti-padgen antibodies |
| 04/15/1993 | CA2119580A1 Production of gpa neurotrophic factor |
| 04/15/1993 | CA2097056A1 Vaccine against neisseria meningitidis infections |
| 04/15/1993 | CA2096411A1 Subunit vaccine for neisseria meningitidis infections and corresponding purified subunits |
| 04/14/1993 | EP0536838A2 Non-A, non-B peptides |
| 04/14/1993 | EP0536807A1 Monoclonal antibodies and their use |
| 04/14/1993 | EP0536564A2 Method to purify streptolysin O, intact streptolysin O obtainable by this method and its use |
| 04/14/1993 | EP0536352A1 Therapeutic and preventive vaccines for hiv |
| 04/14/1993 | EP0536335A1 Compositions and methods for the prevention and diagnosis of lyme disease |
| 04/14/1993 | EP0536322A1 HUMAN MACROPHAGE INFLAMMATORY PROTEIN 2$g(a) |
| 04/14/1993 | EP0536299A1 Surface complexed lymphotoxin |
| 04/14/1993 | EP0536275A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 04/14/1993 | EP0536234A1 Vectors containing hiv packaging sequences, packaging defective hiv vectors, and uses thereof |
| 04/14/1993 | EP0313651B1 Synthetic peptides for diagnosis and prevention of influenza virus infection and their use |
| 04/14/1993 | CN1070946A Composition for introducing nucleic acid complexes into higher eucaryotic cells |
| 04/14/1993 | CN1020253C Pasteurization for immunoglobulin solution |
| 04/13/1993 | US5202430 DNA sequence, encoding, polypeptide, vaccine |
| 04/13/1993 | US5202424 Mesangial cell-derived receptors for advanced glycosylation endproducts and uses thereof |
| 04/13/1993 | US5202422 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins and method of their use |
| 04/13/1993 | US5202252 Monoclonal antibodies against lens epithelial cells and methods for preventing proliferation of remnant lens epithelial cells after extracapsular extraction |
| 04/13/1993 | US5202247 Hybrid protein containing polypeptide fused to substrate binding region of amino acid sequence |
| 04/13/1993 | US5202119 Administering somatomedins |
| 04/12/1993 | WO1993006862A1 Antibody composition |
| 04/12/1993 | CA2097932A1 Antibody containing composition |
| 04/12/1993 | CA2080258A1 Process for the purification of streptolysin o, intact streptolysin o obtainable by this process and its use |
| 04/11/1993 | CA2080309A1 Mutations in ryanodine receptor causative of human malignant hyperthermia |
| 04/08/1993 | CA2079439A1 Non-a, non-b peptides |
| 04/07/1993 | EP0535740A1 Respiratory disease vaccine for cats |
| 04/07/1993 | EP0535084A1 Improved ascites production of monoclonal antibodies using an immunosuppressive anti-cd4-related antibody |
| 04/07/1993 | EP0535021A1 Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome |
| 04/07/1993 | EP0534978A1 Interleukin-1 antagonist and uses thereof |
| 04/07/1993 | EP0233936B1 Synthetic polypeptides for detecting mycobacterial infections |
| 04/07/1993 | CN1070685A Multiple hepatitis B virus surface proteins which form particles |
| 04/06/1993 | US5200508 Cell surface antigen that binds with L6 monoclonal antibody |
| 04/06/1993 | US5200344 Diagnostic testing for campylobacter jejuni or campylobacter coli infections using novel antigens |
| 04/06/1993 | US5200184 Deacylation using hydrolase enzyme |
| 04/06/1993 | US5200179 Containing ascorbic acid or salt inactivated virus or bacterium and a carrier, and free of live viruses or bacteria |
| 04/06/1993 | CA1315716C Monoclonal antibodies to the light chain region of human factor xii and methods of preparing and using the same |
| 04/01/1993 | WO1993006248A1 Detection method for c-raf-1 genes |
| 04/01/1993 | WO1993006233A1 Tumor immunotherapy utilizing a method of overcoming the resistance of a progressively growing tumor |
| 04/01/1993 | WO1993006232A1 HUMAN MONOCLONAL ANTIBODY AGAINST GLYCOPROTEIN IIb/IIIa |
| 04/01/1993 | WO1993006231A1 Anti-human milk fat globule humanised antibodies |
| 04/01/1993 | WO1993006228A1 A new form of liposaccharide binding protein (lbp) |
| 04/01/1993 | WO1993006218A2 Chimeras of parainfluenza virus type 3 proteins f and hn as vaccines |
| 04/01/1993 | WO1993006214A1 Chimeric and/or growth-restricted flaviviruses |
| 04/01/1993 | WO1993006213A1 Production of chimeric antibodies - a combinatorial approach |
| 04/01/1993 | WO1993006211A1 Vaccine for mystery swine disease and method for diagnosis thereof |
| 04/01/1993 | WO1993006135A1 Diagnosing and treating autoimmune disorders |
| 04/01/1993 | WO1993006131A1 Porcine adipocyte antigens and their use in the immunological control of fat |
| 04/01/1993 | WO1993006129A1 Polypeptide inhibitor of the replication of hsu and similar viruses |
| 04/01/1993 | WO1993006126A1 Immunoreactive hepatitis c virus polypeptide compositions |
| 04/01/1993 | WO1993006125A1 ISOLATION AND CHARACTERIZATION OF cDNA OF PLASMODIUM FALCIPARUM GLUCOSE-6-PHOSPHATE DEHYDROGENASE |
| 04/01/1993 | WO1993006116A1 Glial derived neurotrophic factor |
| 04/01/1993 | WO1993005813A1 Method of producing antibodies to a restricted population of t lymphocytes, antibodies and method of use |
| 04/01/1993 | WO1993005812A1 Method to induce cytotoxic t lymphocytes specific for a broad array of hiv-1 isolates using hybrid synthetic peptides |
| 04/01/1993 | WO1993005810A1 VACCINE COMPRISING PART OF CONSTANT REGION OF IgE FOR TREATMENT OF IgE-MEDIATED ALLERGIC REACTIONS |
| 04/01/1993 | WO1993005789A1 Saponin-antigen conjugates and the use thereof |
| 04/01/1993 | WO1993005780A1 Amino acids containing parenteral formulations for the treatment of hypotension and related pathologies |
| 04/01/1993 | WO1993003148A3 Tau/neurofilament protein kinases pk40 and pk36 |
| 04/01/1993 | WO1992022583A3 Tri- and tetra-valent monospecific antigen-binding proteins |
| 04/01/1993 | WO1992018610A3 Compositions and methods for endothelial binding |
| 04/01/1993 | CA2120036A1 Method of producing antibodies to a restricted population of t lymphocytes, antibodies produced therefrom and methods of use thereof |
| 04/01/1993 | CA2116684A1 Amino acids containing parenteral formulations for the treatment of hypotension and related pathologies |
| 04/01/1993 | CA2116033A1 Porcine adipocyte antigens and their use in the immunological control of fat |
| 04/01/1993 | CA2115566A1 Polypeptide inhibitor of the replication of hsu and similar viruses |
| 03/31/1993 | EP0534878A1 Recombinant DNA molecules containing the coding part of a VBeta17 chain of the T cell antigen receptor and uses thereof |
| 03/31/1993 | EP0534764A1 Protein-dimeric polysaccharide conjugate vaccine |
| 03/31/1993 | EP0534742A1 Anti-human milk fat globule humanised antibodies |
| 03/31/1993 | EP0534618A2 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
| 03/31/1993 | EP0534615A2 HLA-restricted hepatitis B virus CTL epitopes |
| 03/31/1993 | EP0534526A1 Treponema hyodysenteriae vaccine |
| 03/31/1993 | EP0534102A1 Human cytomegalovirus specific peptides and use thereof |
| 03/31/1993 | EP0533846A1 The ciliary neurotrophic factor receptor |
| 03/31/1993 | EP0533841A1 Novel methods for producing antigen-specific, high-affinity human monoclonal antibodies |
| 03/31/1993 | EP0533834A1 Intercellular adhesion mediators |
| 03/31/1993 | EP0533830A1 Measuring non-dystrophin proteins and diagnosing muscular dystrophy |
| 03/31/1993 | EP0533744A1 Heterocyclic anthracyclione and anthracycline analogs |
| 03/31/1993 | EP0533690A1 Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs |
| 03/31/1993 | EP0281604B1 Single polypeptide chain binding molecules |
| 03/31/1993 | EP0269729B1 Method of preparing toxoid |
| 03/31/1993 | CN1070409A Prodrug activated by targeted catalytic proteins |
| 03/30/1993 | US5198537 Immunogens for immunoassay |
| 03/30/1993 | US5198536 Peptides comprising an immunogenic site of poliovirus and DNAs containing nucleotide sequences coding for these peptides |
| 03/30/1993 | US5198535 Protective malaria sporozoite surface protein immunogen and gene |
| 03/30/1993 | US5198348 Yeast cell transformation vectors, Saccharomyces |
| 03/30/1993 | US5198347 Dna encoding plasmodium vivax and plasmodium knowlesi duffy receptor |
| 03/30/1993 | US5198215 Composition for controlling mastitis in ruminants, method for its preparation and method of treatment of ruminants |
| 03/30/1993 | US5198214 Anti-mastitis polyvalent vaccine, method of administration and method for production thereof |
| 03/30/1993 | CA1315481C Synthetic polypeptides and antibodies related to epstein-barr virus early antigen-diffuse |
| 03/30/1993 | CA1315226C Process for preparation of improved mutant strain of bordetella bronchiseptica useful for live attenuated vaccine for protection of b. bronchiseptica infection and live attenuatedar vaccine produced therefrom |
| 03/30/1993 | CA1315225C Polypeptide useful for the allevation, treatment and diagnosis of auto-immune diseases, especially arthritic conditions, etc. |
| 03/30/1993 | CA1315224C Biological containment |
| 03/30/1993 | CA1315219C Monoclonal antibodies against human carcinoembryonic antigen, processes for their production and their use |
| 03/27/1993 | CA2079197A1 Recombinant nda new molecules containing the codifying part of a vbeta 17 chain for the t-cells antigene receptor, preparat ion process, antibodies and drugs containing them |
| 03/26/1993 | CA2078851A1 Treponema hyodysenteriae vaccine |